See the Future Clearly
Let's Assess AMD Risk Years Before Vision Loss
Current detection methods identify the disease only after irreversible damage has occurred, when treatment options are limited and costly.
Critical Challenge: Progressive and irreversible vision loss occurs over time. When vision problems become apparent, the damage is permanent and irreversible.
Most vision loss from AMD could be detected with our proactive risk assessment platform that provides early intervention opportunity
What if we could predict vision loss years before it happens?
The market's first blood test opportunity for AMD risk assessment before vision loss begins.
The market's first blood test opportunity for AMD risk assessment before vision loss begins.
Machine learning algorithms deliver 94-95% test accuracy rate in predicting future AMD risk.
AMD Risk Assessment using blood samples in Primary Care during routine family doctor visits.
Medicare reimbursement opportunity under existing preventive care frameworks.
Our AMD risk assessment platform creates value for patients, investors, and the world.
Whether you're a patient, healthcare provider, or investor, we have resources tailored for you.
Learn how our blood-based AMD risk assessment can help detect vision risk years before symptoms appear, enabling early intervention and prevention.
Explore the investment opportunity in the first blood-based AMD risk assessment platform with a $42.3 billion market opportunity and proven business model.
$654,875
Pre-Seed
8 Members
Comprehensive AI model validation with 5+ years of research demonstrating world-class accuracy for AMD risk assessment
| Rank | Model Version | Algorithm | Accuracy | Details | Reproducibility |
|---|---|---|---|---|---|
| 🥇 #1 | Version 11.4/11.5 | Gradient Boosting | 95.45% | Grid Search + Advanced Features | ✅ Perfect |
| 🥈 #2 | Version 11.2.1 | Gradient Boosting | 94.5% | Randomized Search | ✅ Excellent |
COMPLETED
PLANNED
Access our complete methodology, datasets, and validation protocols. Join the future of AI-powered AMD Risk Analysis Platform.
Our experienced leadership team combines deep scientific expertise with proven entrepreneurial success in health innovation.
✓ Join us in revolutionizing vision care through early AMD risk assessment
✓ This investment opportunity represents the convergence of significant unmet medical need, proven technology platform, experienced leadership, and clear regulatory and reimbursement pathways.
